344 related articles for article (PubMed ID: 26388194)
1. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes.
Socher I; Zwingel C; Santoso S; Kroll H
Transfusion; 2008 Mar; 48(3):463-72. PubMed ID: 18067506
[TBL] [Abstract][Full Text] [Related]
3. The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia.
Jallu V; Bertrand G; Bianchi F; Chenet C; Poulain P; Kaplan C
Transfusion; 2013 Mar; 53(3):554-63. PubMed ID: 22738334
[TBL] [Abstract][Full Text] [Related]
4. A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia.
Kroll H; Feldmann K; Zwingel C; Hoch J; Bald R; Bein G; Bayat B; Santoso S
Transfusion; 2011 Aug; 51(8):1745-54. PubMed ID: 21332723
[TBL] [Abstract][Full Text] [Related]
5. The new platelet alloantigen Cab a: a single point mutation Gln 716 His on the alpha 2 integrin.
Bertrand G; Jallu V; Saillant D; Kervran D; Martageix C; Kaplan C
Transfusion; 2009 Oct; 49(10):2076-83. PubMed ID: 19500323
[TBL] [Abstract][Full Text] [Related]
6. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH
Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382
[TBL] [Abstract][Full Text] [Related]
7. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
[TBL] [Abstract][Full Text] [Related]
9. A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia.
Poles A; Woźniak MJ; Walser P; Ridgwell K; Fitzgerald J; Green A; Gilmore R; Lucas G
Transfusion; 2013 Sep; 53(9):1965-73. PubMed ID: 23305224
[TBL] [Abstract][Full Text] [Related]
10. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.
Peterson JA; Gitter ML; Kanack A; Curtis B; McFarland J; Bougie D; Aster R
Transfusion; 2010 Feb; 50(2):324-33. PubMed ID: 19821948
[TBL] [Abstract][Full Text] [Related]
11. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
Lin M; Xu X; Lee HL; Liang DC; Santoso S
Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
[TBL] [Abstract][Full Text] [Related]
12. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
13. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
[TBL] [Abstract][Full Text] [Related]
14. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
15. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glycoprotein IIb/IIIa-specific alloantibodies induced by cross-strain platelet immunization in mice.
Bougie DW; Sutton J; Aster RH
Transfusion; 2021 Apr; 61(4):1278-1285. PubMed ID: 33483962
[TBL] [Abstract][Full Text] [Related]
17. Cab4b, the first human platelet antigen carried by glycoprotein IX discovered in a context of severe neonatal thrombocytopenia.
Jallu V; Beranger T; Bianchi F; Casale C; Chenet C; Ferre N; Philippe S; Quesne J; Martageix C; Petermann R
J Thromb Haemost; 2017 Aug; 15(8):1646-1654. PubMed ID: 28561420
[TBL] [Abstract][Full Text] [Related]
18. Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women.
Jeremiah ZA; Atiegoba AI; Mgbere O
Hum Antibodies; 2011; 20(3-4):71-5. PubMed ID: 22129676
[TBL] [Abstract][Full Text] [Related]
19. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ
Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.
Bakchoul T; Meyer O; Agaylan A; Bombard S; Bein G; Sachs UJ; Salama A; Santoso S
Transfusion; 2007 Aug; 47(8):1363-8. PubMed ID: 17655579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
